MARCH 23, 2017


Biomanufacturing in Canada:

Stimulating the future!

The Fondation Biotech Montréal (FBM), in collaboration with the National Research Council of Canada (NRC), Global Affairs Canada, and LifeSciences BC invite you to a workshop on the industrial and commercial potential of biomanufacturing in Canada.

  • Rich biologics pipeline in Canada
  • Biologics development value chain and biomanufacturing services
  • International perspective from a CMO
  • National perspective from a leading Canadian biotech
  • Roundtable discussion on market opportunities and challenges
  • Networking


NRC Vancouver
4250 Wesbrook Mall
Vancouver, BC
V6T 1W5


7:30 a.m. to 12:00 p.m.


Coffee and pastries will be served

Keynote Speakers

BIOMANUFACTURING IN CANADA: Bernard Massie, General Manager, Human Health Therapeutics, National Research Council Canada

Bernard Massie
General Manager,
Human Health Therapeutics
National Research Council Canada

See Profile
BIOMANUFACTURING IN CANADA: Bernard Massie, General Manager, Human Health Therapeutics, National Research Council Canada

David Poon
Executive Director, External R&D and Alliances

See Profile
BIOMANUFACTURING IN CANADA: Louis-Félix Binette Strategic Advisor Escouade

Stacy Luther
Commercial Development Specialist
FUJIFILM Diosynth Biotechnologies

See Profile
BIOMANUFACTURING IN CANADA: Louis-Félix Binette Strategic Advisor Escouade

Louis-Félix Binette
Strategic Advisor

See Profile

Preliminary Program

7:30 a.m.

Registration and networking
Continental breakfast will be served

8:00 a.m.

Lesley Esford, President, LifeSciences BC

8:10 a.m.

Jean-Philippe Linteau, Director of Life Sciences, Clean Technology & Infrastructure, Global Affairs Canada

Eileen Raymond, Portfolio Business Advisor, National Research Council of Canada

8:20 a.m.

Biomanufacturing in Canada: An opportunity for development?
Bernard Massie, General Manager, Human Health Therapeutics, National Research Council of Canada

Canada has a rich biotech pipeline, but these products developed in Canada are being manufactured abroad.  This presentation will highlight industry trends and set the table for the consultation workshop.

8:40 a.m.


8:45 a.m.

Selecting a CMO: Insights from Canada’s top biopharma company
David Poon, Executive Director, External R&D and Alliances, Zymeworks

Choosing a CMO for GMP production of biologics is a critical aspect in the transition of a product toward clinical trials.  This presentation will highlight the rationale, considerations, selection criteria, and experiences of Canada’s top biopharma company in choosing a CMO.

9:05 a.m.


9:10 a.m.

The Evolution of a CDMO – FUJIFILM Diosynth perspective
Stacy Luther, Commercial Development Specialist, FUJIFILM Diosynth Biotechnologies

This presentation will highlight Fujifilm’s trajectory in the CDMO space, including service offerings added to our portfolio, capacity addition at the US/UK site, and expansion through the acquisition of the Texas site.

9:30 a.m.


9:40 a.m.

Introduction to the consultation workshop
Louis-Félix Binette, Strategic Advisor, Escouade Moderation

In this workshop, we will leverage the collective knowledge and experience of biotech participants to map out how Canada could best create value from biomanufacturing, identify specific opportunities, and establish next steps.

9:55 a.m.

Break and networking

10:25 a.m.

Consultation workshop
All participants – break out discussions and reconvene to share ideas

12:15 p.m.

Closing remarks and next steps
Eileen Raymond on behalf of Nicola Urbani, Member of the Board, Fondation Biotech Montreal

12:30 p.m.

End of the workshop

Register Now!

Take advantage of this unique opportunity to hear our keynote speakers and to contribute in this national effort to establish potential solutions to develop biomanufacturing in Canada.



For the last 15 years, the main goal of Fondation Biotech Montréal (FBM) has been to promote the growth of the Canadian Life Sciences Industry in the area of Human Health. With the leadership of recognized industry members, the FBM, a non-for-profit organization, has worked hand in hand with NRC to provide a forum for technology transfer between Canadian research centres and industry by organizing different editions of the BioTransfer event in Toronto, Montréal and Boston. This success followed the previous 12 editions of the Crossroad of Biotechnology that attracted renowned international keynote speakers around the world to Montréal and gathered the whole biotech community within the walls of NRC-Royalmount.

Since 2016 and to continue in alignment with its mission, FBM is committed to promoting the development of a strong Biomanufacturing Sector in Canada in partnership with NRC – Human Health Therapeutics. This exciting undertaking needs to be developed not only by the FBM and NRC, but in collaboration with all stakeholders which will benefit from the economic impacts of manufacturing biologics in our country.

We hope that the consultation workshop on March 23rd will help identify the opportunities and challenges of biomanufacturing in Canada, and will pave the road to a bright future!

Your participation is greatly appreciated,


Nicola Urbani
President, Board of administrators

In Collaboration With:

For more Information

(514) 439-5538 or 1-844-285-2342

Semaphore DigitalBiomanufacturing in Vancouver – March 23rd, 2017